AA
VSTM icon

AlphaCentric Advisors’s Verastem VSTM Stock Holding History

AlphaCentric Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150,000
Closed -$1.22M – 248
2023
Q4 		$1.22M Hold
150,000
– – 0.82% 48
2023
Q3 		$1.22M Hold
150,000
– – 0.69% 48
2023
Q2 		$1.12M Buy
+150,000
New +$1.04M 0.62% 59

Other funds holding VSTM

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

AlphaCentric Advisors's VSTM Position: Q1 2024 in Review

AlphaCentric Advisors sold out of Verastem (VSTM) in Q1 2024, closing a stake of 150,000 shares — an estimated $1.22M sold.

AlphaCentric Advisors first reported a position in VSTM in Q2 2023 and held it in 3 quarters. The position peaked at $1.22M in Q4 2023. 70 funds tracked by Wall St. Rank hold VSTM as of Q1 2024.

  • AlphaCentric Advisors reported no remaining Verastem position as of Q1 2024 after selling out during the quarter.
  • AlphaCentric Advisors sold 150,000 Verastem shares in Q1 2024, an estimated $1.22M.
  • AlphaCentric Advisors first reported a position in Verastem in Q2 2023 and held it in 3 quarters.
  • AlphaCentric Advisors's Verastem position peaked at $1.22M in Q4 2023.
  • 70 funds tracked by Wall St. Rank held Verastem as of Q1 2024.

Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.